Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

In 2006, Senegal adopted artemisinin-based combination therapy (ACT) as first-line treatment in the management of uncomplicated malaria. This study aimed to update the status of antimalarial efficacy more than ten years after their first introduction. This was a randomized, three-arm, open-label stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Diallo, Mamadou Alpha, Yade, Mamadou Samb, Ndiaye, Yaye Die, Diallo, Ibrahima, Diongue, Khadim, Sy, Saidou Abdoul, Sy, Mouhamad, Seck, Mame Cheikh, Ndiaye, Mouhamadou, Dieye, Baba, Gomis, Jules François, Sow, Djiby, Dème, Awa Bineta, Badiane, Aida Sadikh, Ndiaye, Daouda
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264303/
https://ncbi.nlm.nih.gov/pubmed/32483161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-65553-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars